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Abstract: The aporphine alkaloid magnoflorine, known as a constituent of Asian
Epimedium species, was isolated for the first time from the wild growing European
species, Epimedium alpinum L. Identification was done by comparison with litera-
ture data. The HPLC method was applied for the determination of the content of the
alkaloid in methanolic extracts of plant material. The underground part of E.
alpinum contains 1–2 % of magnoflorine, while its content in methanolic extracts
was 9.2–11.8 %. The aerial part of the plant contains less alkaloid (0.06–0.12 %),
while the magnoflorine content in methanolic extracts of the aerial part was 0.4–0.8
%. Probably, the high content of magnoflorine in the methanolic extracts of under-
ground parts of E. alpinum influences its dose-dependent cytotoxic activity (300
g/ml; 39 % survival of cells in an experimental K562 cell culture).
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INTRODUCTION
In traditional medicine of East Asian countries, aerial parts (leaves or herba) of
several Epimedium species (E. grandiflorum, E. koreanum, E. sagittatum, E. pube-
scens and other) are used in the treatment of renal illness, impotence, infertility in
women, rheuma, asthma, coronary illness, hypertension, etc.1 According to recent
data, over 60 flavonoid glycosides (most of them derivatives of 8-C-prenyl-kaem-
pherol), around 30 flavonoid aglycones and up to 50 other glycosides, known as icari-
sides, have been isolated from different Epimedium species.1 The other pharmacologi-
cally active constituents of Epimedium species are phytosterols, fatty acids, polysac-
charides1 and aporphine type alkaloids (mainly magnoflorine).2,3
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The genus Epimedium is represented by 2 species in Europe (E. pubigerum Morr.
et Decne and Epimedium alpinum L.). In the flora of Serbia and Montenegro, only the
latter species is present. E. alpinum (Berberidaceae), Alpine Barrenwort, has not been
chemically and pharmacologically investigated. In folk medicine, the leaf is used as a
diaphoretic and in breast illness.2 The only data about the chemical constituents of this
species suggest the presence of alkaloids in the underground parts.4
RESULTS AND DISCUSSION
This paper reports for the first time the isolation of the aporphine alkaloid
magnoflorine from the underground parts of E. alpinum, the wild growing Epime-
dium species in Europe. Characterization of magnoflorine (C20H24O4N
+, Mr
342.41) was made by 1H-NMR, 13C-NMR and MS spectroscopy and identifica-
tion was made by comparison with literature data.5 This alkaloid is a well known
constituent of other Epimedium species (E. pubigerum,2 E. cremeum, E. grandi-
florum, E. rugosum3). It was presumed that the aerial parts of Epimedium species
were without alkaloids.3 However, Slavik and co-workers6 isolated magnoflorine
(as the iodide, 0.14 %) from the underground parts of the decorative species E.
versicolor and detected a trace of this alkaloid in the aerial parts. Chen and
co-workers7 confirmed by HPLC that magnoflorine was present in all parts of E.
koreanum, mostly in the rhizome.
TABLE I. The magnoflorine content (%) in the E. alpinum extracts and plant materials, determined
by the HPLC method
Plant material Solvent Mass ratio
drug/extract
Content of
magnoflorine in
the extracts/%
Calculated content of
magnoflorine in the plant
material/%
Underground part
Div~ibare, Aug. 1999
MeOH 8.13 : 1 9.17 1.13
Underground part
Div~ibare, June 2001
MeOH 5.64 : 1 11.82 2.09
Aerial part Div~ibare,
Aug. 1999
MeOH 6.96 : 1 0.85 0.12
Aerial part Div~ibare,
June 2001
MeOH 7.97 : 1 0.46 0.06
Aerial part Div~ibare,
June 2001
H2O 5.26 : 1 0.40 0.07
Qualitative and quantitative analysis of E. alpinum from Serbia indicated the
presence of alkaloids in the underground parts, as well as in the aerial parts. Hitherto,
there were no data about the quantity of alkaloids in E. alpinum. A spectroscopic
method (official method for the quantification of boldine in Boldo folium)8 was used
for alkaloid quantification in plant material and extracts of E. alpinum.9 After isola-
tion of magnoflorine, which is the main alkaloid in E. aplinum, it was possible to ap-
ply the HPLC method for the quantitative determination of the alkaloid content in
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extracts of underground and aerial parts of E. alpinum, using isolated magnoflorine
as the reference substance. Methanolic extracts of underground parts contained
9.2–11.8 % of magnoflorine, while the content of this alkaloid was few time smaller
in the extracts of the aerial parts (0.4–0.8 %) (Table I). When the results were calcu-
lated on plant material, the alkaloid content in the underground parts was much
higher, (1–2 %), than in the aerial parts of E. alpinum (0.06–0.12 %). The HPLC
method is more sutable for the quantitative analysis of alkaloids of E. alpinum than
the spectroscopic method,8 because of the difference in the molecular weight of
boldine and magnoflorine, as well as because of the difference in the solubility of
magnoflorine (as quaternary base is highly water-soluble) and boldine.
Magnoflorine has chemotaxonomic importance as a characteristic alkaloid for
the families of Polycarpicae.6,10 From the pharmacological aspect, it is interesting
as neuromuscular blocking agent11 (AChR blocking agent),12 lipoxygenase inhib-
itor,12,13 as well as for its cytotoxic,14 immunosupressive15 and antimicrobial16
activities. According to the results of a preliminary investigation on cytotoxic ac-
tivity, a methanolic extract of the underground parts of E. alpinum showed strong
activity at a concentration of 300 g/ml against K562 cell line of malignantly-trans-
formed cells.9 Also, the same extract showed immunomodulatory activity in vitro
and in vivo (unpublished results). It is quite possible that these activities could be
explained by the rather high content of magnoflorine in methanolic extracts of the
underground parts of E. alpinum (9.2–11.8 %).
EXPERIMENTAL
Plant material
Plant material (underground parts = root and rhizome; aerial parts = leaves) was collected on
Div~ibare (mountain Maljen, western Serbia) in August 1999. and in June 2001. After collection, the
plant material was dried in thin layers, in the shade, by air circulation and powdered prior to extraction.
Isolation and characterization of magnoflorine
The methanolic extract of the underground parts was dissolved in hot distilled water and ex-
tracted with diethyl ether, ethyl acetate and n-butanol. The aqueous phase was alkalinized with
NH4OH to pH 10 and extracted with chloroform (extraction of tertiary alkaloids). The alkaline aque-
ous phase was acidified with HCl to pH 3 and treated with an aqueous solution of picric acid (1 %), in
order to precipitate quaternary alkaloids. After 24 h, the precipitate was dissolved in MeOH, treated
with activated charcoal and filtered over Celite. The methanolic solution was passed through an
ion-exchange resin (Amberlite IRA 400 OH-) column, evaporated and further purified by preparative
chromatography on silica gel (mobile phase: MeOH–H2O–25 % NH3, 15:3:1) to obtain magnoflorine
(Rf 0.3, blue fluorescent band at 365 nm, red after treatment with Dragendorf’s reagent). The
1H-NMR
(200 Mz, CD3OD) and
13C-NMR (50 MHz, CD3OD) spectra were recorded on a Varian Gemini –
2000 instrument. The mass spectrum was recorded on a Finnigan MAT 8230 instrument.
Preparation of extracts for quantitative analysis
Methanolic extract: Powdered plant material (aerial parts 574 g; underground parts 474 g) was
extracted by maceration at room temperature, with frequent shaking, first with CHCl3 (2  2.5 l),
during 3 days, then with MeOH (2  2.5 l), during 7 days. Aqueous extract of the aerial parts: Pow-
dered plant material (108 g) was extracted with distilled water (1300 ml) at 100 ºC for 1 h. The ex-
tracts were evaporated to dryness under vacuum at 40 ºC.
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Analytical HPLC
HPLC determination was performed on a Perkin Elmer instrument with a UV/VIS LC 290
Spectrophotometric Detector and LC 250 Pump on a Bakerbond BDC column (250 mm  4.6 mm; 5
m), using methanol–glacial acetic acid–triethanolamine–water (30 : 1 : 0.5 : 68.5), pH 5 as the mo-
bile phase. Other conditions: temperature – ambient, flow rate – 1 ml/min, paper rate – 10 mm/min,
sensitivity – 0.2 mAu, injection volume – 5 l, detection at 270 nm. The reference solution was pre-
pared by dissolving 16.7 mg of magnoflorine in 10 ml of methanol.
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Aporfinski alkaloid magnoflorin, poznat kao sastojak drugih vrsta roda Epi-
medium, po prvi put je izolovan iz evropske vrste Epimedium alpinum L. i identifiko-
van pore|ewem sa literaturnim podacima. Ovo jediwewe je kori{}eno kao standard u
HPLC analizi metanolnih ekstrakata E. alpinum. Sadr`aj magnoflorina je znatno vi-
{i u ekstraktima podzemnih organa (9,2–11,8 %, {to odgovara sadr`aju od 1–2 % mag-
noflorina u biqnom materijalu), nego u ekstraktima nadzemnih organa prevolca
(0,4–0,8 %, {to odgovara sadr`aju od 0,06–0,12 % magnoflorina u biqnom materijalu).
Sasvim je verovatno da je potvr|ena citotoksi~na aktivnost metanolnog ekstrakta
podzemnih organa (300 g/ml; 39 % pre`ivelih }elija K562 kulture maligno-trans-
formisanih }elija), kao i imunomodulatorna aktivnost, povezana sa visokom koncen-
tracijom ovog alkaloida u ispitivanom ekstraktu.
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